Abstract
MicroRNAs (miRNAs) are small noncoding RNAs that are emerging as pivotal modulators in virtually all aspects of cardiac biology, from cardiac development to cardiomyocyte survival and hypertrophy. The miRNA profiling, following gain- and loss-of-function studies using in vitro and in vivo models, has identified wide-ranging functions for miRNAs in the heart, providing new perspectives on their contributions to cardiac pathogenesis, and revealing potential therapeutic targets and diagnostic biomarkers. This review summarizes current progress in regulation of miRNAs in heart development and disease.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
De Rosa S, Fichtlscherer S, Lehmann R, et al. Transcoronary concentration gradients of circulating microRNAs. Circulation, 2011, 124: 1936–1944
Kiriakidou M, Tan G S, Lamprinaki S, et al. An mRNA m7G cap binding-like motif within human Ago2 represses translation. Cell, 2007, 129: 1141–1151
Bagga S, Bracht J, Hunter S, et al. Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell, 2005, 122: 553–563
Bauersachs J, Thum T. Biogenesis and regulation of cardiovascular microRNAs. Circ Res, 2011, 109: 334–347
Lagos-Quintana M, Rauhut R, Yalcin A, et al. Identification of tissue-specific microRNAs from mouse. Curr Biol, 2002, 12: 735–739
Chendrimada T P, Gregory R I, Kumaraswamy E, et al. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature, 2005, 436: 740–744
Sayed D, Hong C, Chen I Y, et al. MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res, 2007, 100: 416–424
Tatsuguchi M, Seok H Y, Callis T E, et al. Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J Mol Cell Cardiol, 2007, 42: 1137–1141
van Rooij E, Sutherland L B, Liu N, et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA, 2006, 103: 18255–18260
Darnell D K, Kaur S, Stanislaw S, et al. MicroRNA expression during chick embryo development. Dev Dyn, 2006, 235: 3156–3165
Zhao Y, Samal E, Srivastava D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature, 2005, 436: 214–220
Zhao Y, Ransom J F, Li A, et al. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell, 2007, 129: 303–317
Sokol N S, Ambros V. Mesodermally expressed Drosophila microRNA-1 is regulated by Twist and is required in muscles during larval growth. Genes Dev, 2005, 19: 2343–2354
Costantini D L, Arruda E P, Agarwal P, et al. The homeodomain transcription factor Irx5 establishes the mouse cardiac ventricular repolarization gradient. Cell, 2005, 123: 347–358
Liu N, Bezprozvannaya S, Williams A H, et al. microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. Genes Dev, 2008, 22: 3242–3254
Levy D, Garrison R J, Savage D D, et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med, 1990, 322: 1561–1566
Rajabi M, Kassiotis C, Razeghi P, et al. Return to the fetal gene program protects the stressed heart: a strong hypothesis. Heart Fail Rev, 2007, 12: 331–343
van Rooij E, Sutherland L B, Liu N, et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA, 2006, 103: 18255–18260
Chen J F, Murchison E P, Tang R, et al. Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure. Proc Natl Acad Sci USA, 2008, 105: 2111–2116
Cheng Y, Ji R, Yue J, et al. MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy? Am J Pathol, 2007, 170: 1831–1840
Sayed D, Hong C, Chen I Y, et al. MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res, 2007, 100: 416–424
Ikeda S, Kong S W, Lu J, et al. Altered microRNA expression in human heart disease. Physiol Genomics, 2007, 31: 367–373
Tatsuguchi M, Seok H Y, Callis T E, et al. Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J Mol Cell Cardiol, 2007, 42: 1137–1141
Thum T, Galuppo P, Wolf C, et al. MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation, 2007, 116: 258–267
Olson E N, Schneider M D. Sizing up the heart: development redux in disease. Genes Dev, 2003, 17: 1937–1956
Tay Y, Zhang J, Thomson A M, et al. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature, 2008, 455: 1124–1128
Wilkins B J, Molkentin J D. Calcium-calcineurin signaling in the regulation of cardiac hypertrophy. Biochem Biophys Res Commun, 2004, 322: 1178–1191
Lin Z, Murtaza I, Wang K, et al. miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy. Proc Natl Acad Sci USA, 2009, 106: 12103–12108
Ikeda S, He A, Kong S W, et al. MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes. Mol Cell Biol, 2009, 29: 2193–2204
Da C M P, Salic K, Gladka M M, et al. MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling. Nat Cell Biol, 2010, 12: 1220–1227
Care A, Catalucci D, Felicetti F, et al. MicroRNA-133 controls cardiac hypertrophy. Nat Med, 2007, 13: 613–618
van Rooij E, Sutherland L B, Qi X, et al. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science, 2007, 316: 575–579
Callis T E, Pandya K, Seok H Y, et al. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J Clin Invest, 2009, 119: 2772–2786
Nishi H, Ono K, Horie T, et al. MicroRNA-27a regulates beta cardiac myosin heavy chain gene expression by targeting thyroid hormone receptor beta1 in neonatal rat ventricular myocytes. Mol Cell Biol, 2011, 31: 744–755
Ago T, Sadoshima J. Thioredoxin1 as a negative regulator of cardiac hypertrophy. Antioxid Redox Signal, 2007, 9: 679–687
Yang Y, Ago T, Zhai P, et al. Thioredoxin 1 negatively regulates angiotensin II-induced cardiac hypertrophy through upregulation of miR-98/let-7. Circ Res, 2011, 108: 305–313
Wu K H, Mo X M, Han Z C, et al. Stem cell engraftment and survival in the ischemic heart. Ann Thorac Surg, 2011, 92: 1917–1925
Mann D L, Bogaev R, Buckberg G D. Cardiac remodelling and myocardial recovery: lost in translation? Eur J Heart Fail, 2010, 12: 789–796
Ren X P, Wu J, Wang X, et al. MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20. Circulation, 2009, 119: 2357–2366
Zhang X, Wang X, Zhu H, et al. Synergistic effects of the GATA-4-mediated miR-144/451 cluster in protection against simulated ischemia/reperfusion-induced cardiomyocyte death. J Mol Cell Cardiol, 2010, 49: 841–850
Dong S, Cheng Y, Yang J, et al. MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction. J Biol Chem, 2009, 284: 29514–29525
Xu C, Lu Y, Pan Z, et al. The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. J Cell Sci, 2007, 120: 3045–3052
Shan Z X, Lin Q X, Fu Y H, et al. Upregulated expression of miR-1/miR-206 in a rat model of myocardial infarction. Biochem Biophys Res Commun, 2009, 381: 597–601
Rowland R T, Meng X, Cleveland J C, et al. Cardioadaptation induced by cyclic ischemic preconditioning is mediated by translational regulation of de novo protein synthesis. J Surg Res, 1997, 71: 155–160
Murry C E, Jennings R B, Reimer K A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation, 1986, 74: 1124–1136
Rane S, He M, Sayed D, et al. Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circ Res, 2009, 104: 879–886
Lim J H, Lee Y M, Chun Y S, et al. Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha. Mol Cell, 2010, 38: 864–878
Qian L, Van Laake L W, Huang Y, et al. miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes. J Exp Med, 2011, 208: 549–560
Wang J X, Jiao J Q, Li Q, et al. miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1. Nat Med, 2011, 17: 71–78
Di Diego J M, Antzelevitch C. Ischemic ventricular arrhythmias: Experimental models and their clinical relevance. Heart Rhythm, 2011, 8: 1963–1968
Mill J G, Stefanon I, Dos S L, et al. Remodeling in the ischemic heart: the stepwise progression for heart. Braz J Med Biol Res, 2011, 44: 890–898
Yang B, Lin H, Xiao J, et al. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med, 2007, 13: 486–491
Lerner D L, Yamada K A, Schuessler R B, et al. Accelerated onset and increased incidence of ventricular arrhythmias induced by ischemia in Cx43-deficient mice. Circulation, 2000, 101: 547–552
Plaster N M, Tawil R, Tristani-Firouzi M, et al. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen’s syndrome. Cell, 2001, 105: 511–519
Luo X, Lin H, Pan Z, et al. Down-regulation of miR-1/miR-133 contributes to re-expression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart. J Biol Chem, 2008, 283: 20045–20052
Michels G, Er F, Khan I, et al. Single-channel properties support a potential contribution of hyperpolarization-activated cyclic nucleotide-gated channels and If to cardiac arrhythmias. Circulation, 2005, 111: 399–404
Matkovich S J, Wang W, Tu Y, et al. MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts. Circ Res, 2010, 106: 166–175
Lu Y, Zhang Y, Wang N, et al. MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation. Circulation, 2010, 122: 2378–2387
Valadi H, Ekstrom K, Bossios A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol, 2007, 9: 654–659
Hunter M P, Ismail N, Zhang X, et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS ONE, 2008, 3: e3694
Rabinowits G, Gercel-Taylor C, Day J M, et al. Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer, 2009, 10: 42–46
Camussi G, Deregibus M C, Bruno S, et al. Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int, 2010, 78: 838–848
Kogure T, Lin W L, Yan I K, et al. Intercellular nanovesicle-mediated microRNA transfer: A mechanism of environmental modulation of hepatocellular cancer cell growth. Hepatology, 2011, 54: 1237–1248
Turchinovich A, Weiz L, Langheinz A, et al. Characterization of extracellular circulating microRNA. Nucleic Acids Res, 2011, 39: 7223–7233
Ji X, Takahashi R, Hiura Y, et al. Plasma miR-208 as a biomarker of myocardial injury. Clin Chem, 2009, 55: 1944–1949
Wang G K, Zhu J Q, Zhang J T, et al. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J, 2010, 31: 659–666
D’Alessandra Y, Devanna P, Limana F, et al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J, 2010, 31: 2765–2773
Ai J, Zhang R, Li Y, et al. Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochem Biophys Res Commun, 2010, 391: 73–77
Cheng Y, Tan N, Yang J, et al. A translational study of circulating cell-free microRNA-1 in acute myocardial infarction. Clin Sci (Lond), 2010, 119: 87–95
Li S, Zhu J, Zhang W, et al. Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection. Circulation, 2011, 124: 175–184
Corsten M F, Dennert R, Jochems S, et al. Circulating microRNA-208b and microRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet, 2010, 3: 499–506
Cheng Y, Tan N, Yang J, et al. A translational study of circulating cell-free microRNA-1 in acute myocardial infarction. Clin Sci (Lond), 2010, 119: 87–95
Kuwabara Y, Ono K, Horie T, et al. Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage. Circ Cardiovasc Genet, 2011, 4: 446–454
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is published with open access at Springerlink.com
Rights and permissions
Open Access This is an open access article distributed under the terms of the Creative Commons Attribution Noncommercial License (https://creativecommons.org/licenses/by-nc/2.0), which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
About this article
Cite this article
Feng, Y., Yu, X. Cardinal roles of miRNA in cardiac development and disease. Sci. China Life Sci. 54, 1113–1120 (2011). https://doi.org/10.1007/s11427-011-4257-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-011-4257-8